11:29 AM EDT, 07/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.69% to 1,421.31 on the S&P Europe Select ADR Index. Despite the increase, the index remains marginally lower for the week.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and oil and gas company Eni (E), which climbed 10.2% and 4.1% respectively. They were followed by consumer goods company Unilever ( UL ) and telecommunications company Ericsson (ERIC), which were up 1.3% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and semiconductor company Sequans Communications ( SQNS ) , which fell 5.8% and 4% respectively. They were followed by 3D printer company Materialise (MTLS) and furniture maker Natuzzi (NTZ), which lost 4.8% and 2.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and TC Biopharm ( TCBP ) , which increased by 3.8% each. They were followed by biopharmaceutical company NuCana ( NCNA ) and construction materials supplier CRH (CRH), which increased 3.6% and 2.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Biodexa Pharmaceuticals ( BDRX ) , which dropped 3.5% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Trinity Biotech ( TRIB ) , which fell 2.3% and 1.7% respectively.